Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cipralex in Polycystic Ovary Syndrome
NCT01961180Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jun 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Quality of Life at 14 weeks. Started Jun 2013; status: completed.
02
Drugs
escitalopram
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT01961180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961180.